Sodium‐Glucose Cotransporter 2 Inhibition for the Prevention of Cardiovascular Events in Patients With Type 2 Diabetes Mellitus: A Systematic Review and Meta‐Analysis

Sodium‐Glucose Cotransporter 2 Inhibition for the Prevention of Cardiovascular Events in Patients With Type 2 Diabetes Mellitus: A Systematic Review and Meta‐Analysis

Background Several trials have demonstrated protective effects from inhibition of sodium‐glucose cotransporter 2 among patients with type 2 diabetes mellitus. There is uncertainty about the consistency of the cardiovascular benefits achieved across patient subsets. Methods and Results We included 4...

Full description

Bibliographic Details
Main Authors: Clare Arnott, Qiang Li, Amy Kang, Brendon L. Neuen, Severine Bompoint, Carolyn S. P. Lam, Anthony Rodgers, Kenneth W. Mahaffey, Christopher P. Cannon, Vlado Perkovic, Meg J. Jardine, Bruce Neal
Format: Article
Language:English
Published: Wiley 2020-02-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
cardiovascular disease
meta‐analysis
sodium‐glucose cotransporter 2 inhibition
type 2 diabetes mellitus
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.119.014908

Similar Items

Similar Items